NIR-II bioimaging of small molecule fluorophores: From basic research to clinical applications

C Li, X Guan, X Zhang, D Zhou, S Son, Y Xu… - Biosensors and …, 2022 - Elsevier
Due to the low autofluorescence and deep-photo penetration, the second near-infrared
region fluorescence imaging technology (NIR-II, 1000–2000 nm) has been widely utilized in …

Multimorbidity, frailty and diabetes in older people–identifying interrelationships and outcomes

AJ Sinclair, AH Abdelhafiz - Journal of personalized medicine, 2022 - mdpi.com
Multimorbidity and frailty are highly prevalent in older people with diabetes. This high
prevalence is likely due to a combination of ageing and diabetes-related complications and …

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort

R McQueenie, HME Foster, BD Jani, SV Katikireddi… - PloS one, 2020 - journals.plos.org
Background It is now well recognised that the risk of severe COVID-19 increases with some
long-term conditions (LTCs). However, prior research primarily focuses on individual LTCs …

Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies

P Hanlon, BD Jani, B Nicholl, J Lewsey… - PLoS …, 2022 - journals.plos.org
Background Cohorts such as UK Biobank are increasingly used to study multimorbidity;
however, there are concerns that lack of representativeness may lead to biased results. This …

An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes

P Hanlon, BD Jani, E Butterly, B Nicholl… - Communications …, 2021 - nature.com
Background Frailty and multimorbidity are common in type 2 diabetes (T2D), including
people< 65 years. Guidelines recommend adjustment of treatment targets in people with …

Multimorbidity and catastrophic health expenditure among patients with diabetes in China: a nationwide population-based study

Y Fu, M Chen, L Si - BMJ Global Health, 2022 - gh.bmj.com
Introduction Multimorbidity is common among patients with diabetes and can lead to
catastrophic health expenditure (CHE) for their families. This study aims to investigate the …

Estimating and characterizing the burden of multimorbidity in the community: A comprehensive multistep analysis of two large nationwide representative surveys in …

J Coste, JM Valderas, L Carcaillon-Bentata - PLoS Medicine, 2021 - journals.plos.org
Background Given the increasing burden of chronic conditions, multimorbidity is now a
priority for healthcare and public health systems worldwide. Appropriate methodological …

Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings

MK Sullivan, BD Jani, A McConnachie, P Hanlon… - BMC medicine, 2021 - Springer
Background Chronic kidney disease (CKD) typically co-exists with multimorbidity (presence
of 2 or more long-term conditions: LTCs). The associations between CKD, multimorbidity …

The relationship between high-density lipoprotein cholesterol (HDL-C) and glycosylated hemoglobin in diabetic patients aged 20 or above: a cross-sectional study

R Huang, L Yan, Y Lei - BMC endocrine disorders, 2021 - Springer
Aim The incidence rate of diabetes is increasing year by year, seriously threatening human
health. As a predictor of glycemic control, glycated hemoglobin is reported to be related to …

Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: a population-based cohort study with 16-year follow-up

JKN Chan, CSM Wong, PCF Or, EYH Chen… - European …, 2021 - Elsevier
Schizophrenia is associated with increased prevalence of diabetes. However, risk of
diabetes complications as well as the impact of complication burden and patterns on …